Evidence map›Paper›PMID 29699222›Full record

ReviewReproductive medicine and biology2005

New regulatory mechanisms for human extravillous trophoblast invasion.

Hiroshi Fujiwara, Yukiyasu Sato, Yoshihiro Nishioka, Shinya Yoshioka, Kenzo Kosaka, Haruko Fujii, Keiji Tatsumi, Miho Egawa, Bin-Xiang Zeng, Kazumi Furukawa and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Reproductive medicine and biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Regulation and Function of Chemokines at the Maternal-Fetal Interface.Frontiers in cell and developmental biology · 2022
    Review
  4. Article
  5. New discoveries on the biology and detection of human chorionic gonadotropin.Reproductive biology and endocrinology : RB&E · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Hiroshi FujiwaraDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Yukiyasu SatoDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Yoshihiro NishiokaDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Shinya YoshiokaDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Kenzo KosakaDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Haruko FujiiDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Keiji TatsumiDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Miho EgawaDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Bin-Xiang ZengDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Kazumi FurukawaDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Toshihiro HiguchiDepartment of Gynecology and Obstetrics, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Kyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human extravillous trophoblasts (EVT) invade maternal deciduas and reconstructed maternal spiral arteries during early placentation. However, the precise regulatory mechanisms to induce EVT invasion toward arteries and/or to protect EVT from further invasion have not been well understood. Recently, it was found that EVT that had already ceased their invasion, specifically expressed cluster of differentiation (CD9) and dipeptidyl peptidase IV (DPPIV) on their cell surface. In addition, EVT migrating to maternal spiral arteries expressed CC chemokine receptor type-1 (CCR-1), which is a chemokine receptor for regulated on activation normal T cell expressed and secreted (RANTES) and so on. CD9 is associated with integrin molecules on the cell surface and is considered to modulate integrin function. In contrast, DPPIV is a cell surface peptidase that can metabolize RANTES at extracellular sites before its accessing to the chemokine receptors.

Indexed as

CD9chemokineextravillous trophoblastintegrininvasionmembrane‐bound peptidase

Identifiers

PMID29699222
PMCPMC5906882
OpenAlexW1972184917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.